SHYNDEC (600420)
Shanghai Shyndec Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. The company provide...
- Open
- 8.50
- High
- 8.58
- Low
- 8.47
- Prev. Close
- 8.48
- Volume
- 58.97K
- Turnover
- 50.30M
- Avg Price
- 8.53
- Bid/Ask Ratio
- --
- Amplitude
- 1.30%
- 52wk High
- 11.37
- Volume Ratio
- 0.38
- Turnover Ratio
- 0.44%
SHYNDEC Analyst Rating
View moreForecast & Rating
Jun 13, 2025Price forecast
¥19.52129.92%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Aug 19 at 02:00 PM
Sinopharm sells 30.13% stake in Guorui Pharma to Shanghai Shyndec for RMB 240.07 million
- 同壁财经 · May 25 at 11:26 AM
Gaoxin Modern's 2025 annual equity distribution plan: a cash dividend of 0.2 yuan for every 10 shares
- Zhitong · Nov 3, 2025 at 09:13 AM
SHYNDEC's holding subsidiary signs the "Drug Marketing Authorization Transfer Agreement"
- Zhitong · Oct 17, 2025 at 11:29 AM
SHYNDEC: Famotidine injection has passed the consistency evaluation of quality and efficacy for generic drugs
- Zhitong · Oct 10, 2025 at 09:30 AM
The subsidiary of SHYNDEC, the raw material drug for sitagliptin phosphate, has received the approval notice for its listing application
- Zhitong · Sep 22, 2025 at 08:59 AM
SHYNDEC: SHYNDEC Rongsheng Vitamin B6 Injection increases specifications and passes consistency evaluation
